BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 11, 2004
View Archived Issues
Genmab highlights first quarter progress
Read More
Xenova make considerable progress during first quarter
Read More
GenVec focuses on progressing TNFerade into later stage clinical trials
Read More
Montelukast sodium may improve sleep disordered breathing in children
Read More
Update on the pharmacokinetics and effects of ciclesonide in asthma
Read More
Clinical response achieved with clofarabine in pediatric acute leukemia
Read More
Perifosine reported well tolerated in advanced cancer patients
Read More
Novel protein-tyrosine-phosphatase 1B inhibitor improves glucose homeostasis in vivo
Read More
Novel PPARgamma activator ameliorates insulin resistance via elevated adiponectin levels
Read More
Pharmacokinetics of new polyenemacrolide antifungal agent in rats
Read More
Novel DPP-IV inhibitor improves glucose tolerance but does not affect diabetes progression
Read More
Paired biopsy study shows normal bone formation after five years of risedronate
Read More
Orphan drug designation for Thymosin beta4 for epidermolysis bullosa
Read More
Canadian approval of Aldurazyme for MPS I
Read More
Proof-of-concept study begins for HCV-086
Read More
Phase II alfimeprase study in venous catheter occlusion completes interim analysis
Read More
Sativex produces positive results in phase II rheumatoid arthritis study
Read More
Isis to acquire Elan's interest in Orasense and HepaSense joint ventures
Read More
Promising phase II results for MDX-060 in Hodgkin's disease
Read More
Orphan drug status for MDX-101
Read More
Positive results for ATL-1102 for multiple sclerosis
Read More
Adenovirus vector VRX-011 has enhanced specific oncolytic efficacy and restriction in primary cells
Read More
Liraglutide reduces body weight in preclinical and clinical studies
Read More
Axokine benefits overweight, diabetic patients
Read More
GSK team describes new prostanoid EP1 modulators for pain and other disorders
Read More
New antibacterial and antifungal agents identified at GeneSoft
Read More
Novel Raf kinase inhibitors in early development at Merck KGaA
Read More
Merck Frosst describes a novel series of NO-releasing COX-2 inhibitors
Read More
Pfizer claims new ziprasidone derivatives and their use as antipsychotics
Read More
Triazole-based vasopressin V1a antagonists and their use in dysmenorrhea therapy
Read More
New nuclear hormone receptor ligands covered by Karo Bio patent
Read More
New glucocorticosteroids prepared and tested at GSK
Read More